Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0021 | 0.9 |
mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |